Valuation: SK Biopharmaceuticals Co., Ltd.

Capitalization 7,275B 5.31B 4.6B 4.33B 3.94B 7.29B 459B 8.21B 51.33B 19.64B 210B 19.91B 19.48B 774B P/E ratio 2025 *
52.8x
P/E ratio 2026 * 26.9x
Enterprise value 6.86B 5M 4.34M 4.09M 3.71M 6.87M 433M 7.74M 48.41M 18.52M 199M 18.77M 18.37M 730M EV / Sales 2025 *
9.82x
EV / Sales 2026 * 7.36x
Free-Float
35.81%
Yield 2025 *
-
Yield 2026 * 0.05%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.99%
1 week+2.88%
Current month-0.11%
1 month+0.43%
3 months-11.10%
6 months-9.01%
Current year-16.38%
More quotes
1 week 89,500
Extreme 89500
94,000
1 month 87,900
Extreme 87900
95,200
Current year 86,900
Extreme 86900
129,800
1 year 72,600
Extreme 72600
130,000
3 years 50,900
Extreme 50900
130,000
5 years 50,900
Extreme 50900
269,500
10 years 50,900
Extreme 50900
269,500
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 52 -
Director TitleAgeSince
Director/Board Member 68 2019-08-26
Director/Board Member 55 2019-08-26
Director/Board Member 53 2023-03-27
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.99%+2.88%+22.24%+31.77% 5.31B
+1.24%-3.92%-33.85%-30.48% 55.29B
-0.64%-1.44%-8.84%-18.00% 8.91B
-0.64%-2.17%+2.44%+15.05% 6.51B
+3.07%-2.16%+34.28%+107.37% 5.65B
-1.24%-13.37%+53.28%-4.86% 3.22B
-2.06%+0.78%+19.38%+16.28% 2.02B
-0.10%-3.42%-1.97%+13.57% 1.95B
+1.95%+2.15%-20.38%-28.29% 1.76B
-0.95%-2.04%-58.85%-15.13% 1.72B
Average +0.34%-2.38%+0.77%+8.73% 9.23B
Weighted average by Cap. +0.90%-3.08%-16.82%-10.87%
See all sector performances

Financials

2025 *2026 *
Net sales 698B 509M 442M 416M 378M 699M 44.11B 788M 4.93B 1.89B 20.21B 1.91B 1.87B 74.27B 901B 657M 570M 537M 488M 902M 56.88B 1.02B 6.35B 2.43B 26.06B 2.46B 2.41B 95.78B
Net income 138B 100M 87.1M 82.05M 74.55M 138M 8.7B 155M 972M 372M 3.98B 377M 369M 14.65B 270B 197M 171M 161M 146M 271M 17.08B 305M 1.91B 730M 7.82B 740M 724M 28.76B
Net Debt -414B -302M -262M -247M -224M -415M -26.16B -467M -2.92B -1.12B -11.99B -1.13B -1.11B -44.06B -651B -475M -412M -388M -352M -652M -41.11B -734M -4.59B -1.76B -18.83B -1.78B -1.74B -69.22B
More financial data * Estimated data
Logo SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
Employees
241
More about the company
Date Price Change Volume
25-06-20 92,900.00 +2.99% 262,289
25-06-19 90,200.00 -0.88% 132,992
25-06-18 91,000.00 -0.11% 110,281
25-06-17 91,100.00 -0.87% 133,232
25-06-16 91,900.00 +1.77% 143,572

End-of-day quote Korea S.E., June 19, 2025

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
92,900.00KRW
Average target price
138,066.67KRW
Spread / Average Target
+48.62%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A326030 Stock